România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

octapharma pharmazeutika produktionsges m.b.h. - austria - imunoglobulina umana normala - sol. inj. subcutana - 165mg/ml - imunoglobuline imunoglobulina umana de origine umana

Uniunea Europeană - română - EMA (European Medicines Agency)

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaccinuri - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. utilizarea acestui vaccin ar trebui să fie în conformitate cu recomandările oficiale.

Uniunea Europeană - română - EMA (European Medicines Agency)

abbvie deutschland gmbh co. kg - adalimumab - spondylitis, ankylosing; arthritis, juvenile rheumatoid; uveitis; colitis, ulcerative; psoriasis; arthritis, psoriatic; crohn disease; arthritis, rheumatoid - imunosupresoare - consultați documentul cu informații despre produs.

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

b. braun melsungen ag - germania - combinatii (lipide) - emulsie perf. - 200mg/ml - solutii pentru administrare intravenoasa solutii pentru nutritie parenterala

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

mip pharma gmbh - germania - clindamycinum - sol. inj./perf. - 150 mg/ml - macrolide, lincosamide si streptogramine lincosamide

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

arena group s.a. - romania - fluconazolum - sol. perf. - 2mg/ml - antimicotice de uz sistemic derivati de triazol

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

antibiotice s.a. - romania - ampicillinum + sulbactam - pulb. pt. sol. inj./perf. - 1000mg/500mg - antibiotice beta-lactamice, peniciline peniciline in combinatii incl. inhibitori de betalactamaza

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

mip pharma gmbh - germania - cefepimum - pulb. pt. sol. inj./perf. - 1g - alte antibiotice betalactamice cefalosporine de generatia a iv-a

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

mip pharma gmbh - germania - cefepimum - pulb. pt. sol. inj./perf. - 2g - alte antibiotice betalactamice cefalosporine de generatia a iv-a

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

csl behring gmbh - germania - diverse - solv. pt. prep. parent. - preparate fara actiune terapeutica solventi si agenti pentru dilutii, incl. sol. pentru irigare